{ "cik": 1341235, "cik_padded": "0001341235", "entityName": "Aldeyra Therapeutics, Inc.", "fiscal_years": [ { "accn": "0001193125-26-083012", "filed": "2026-02-27", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "cash": "USD", "eps_diluted": "USD/shares", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 70041254.0, "eps_diluted": -0.56, "net_income": -33846661.0, "operating_cash_flow": -33345682.0, "operating_income": -35265206.0, "stockholders_equity": 44250390.0, "total_assets": 72059317.0, "total_liabilities": 27808927.0 }, "period_end": "2025-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.6284447888481887, "roa_avg2y": -0.3831711692409243, "roa_period_end": -0.46970554827767796, "roe_avg2y": -0.5873339005323149, "roe_period_end": -0.764889552385866 } }, { "accn": "0001193125-26-083012", "filed": "2026-02-27", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "cash": "USD", "eps_diluted": "USD/shares", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 54527092.0, "eps_diluted": -0.94, "net_income": -55851444.0, "operating_cash_flow": -43208747.0, "operating_income": -60117032.0, "stockholders_equity": 71004871.0, "total_assets": 104606694.0, "total_liabilities": 33601823.0 }, "period_end": "2024-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.47323264625042416, "roa_avg2y": -0.44162928844508426, "roa_period_end": -0.5339184507637723, "roe_avg2y": -0.5854452094291182, "roe_period_end": -0.7865860921006391 } }, { "accn": "0001193125-26-083012", "filed": "2026-02-27", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "eps_diluted": "USD/shares", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "eps_diluted": -0.64, "net_income": -37542510.0, "operating_cash_flow": -30326128.0, "operating_income": -42794083.0, "stockholders_equity": 119795030.0, "total_assets": 148326911.0, "total_liabilities": 28531881.0 }, "period_end": "2023-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.23817249346654865, "roa_avg2y": -0.22779365997366993, "roa_period_end": -0.2531065316933621, "roe_avg2y": -0.2772679905362517, "roe_period_end": -0.3133895454594402 } }, { "accn": "0000950170-25-030102", "filed": "2025-02-28", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "cash": "USD", "eps_diluted": "USD/shares", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 144419364.0, "eps_diluted": -1.06, "net_income": -62024636.0, "operating_cash_flow": -56637187.0, "operating_income": -62679987.0, "stockholders_equity": 151008029.0, "total_assets": 181291657.0, "total_liabilities": 30283628.0 }, "period_end": "2022-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.20054316449624013, "roa_avg2y": -0.29932591288176885, "roa_period_end": -0.34212625680838693, "roe_avg2y": -0.3477267390105484, "roe_period_end": -0.41073733900599424 } }, { "accn": "0000950170-24-027933", "filed": "2024-03-07", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "cash": "USD", "eps_diluted": "USD/shares", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 229790989.0, "eps_diluted": -1.07, "net_income": -57776274.0, "operating_cash_flow": -42555907.0, "operating_income": -56219536.0, "stockholders_equity": 205735523.0, "total_assets": 233137120.0, "total_liabilities": 27401597.0 }, "period_end": "2021-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.13318845768798032, "roa_avg2y": -0.36510690905022186, "roa_period_end": -0.24782099907556548, "roe_avg2y": -0.43564609458712106, "roe_period_end": -0.28082789572513445 } }, { "accn": "0000950170-23-006998", "filed": "2023-03-09", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "cash": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 77858311.0, "net_income": -37553729.0, "operating_cash_flow": -37493455.0, "operating_income": -36421020.0, "stockholders_equity": 59508558.0, "total_assets": 83352503.0, "total_liabilities": 23843945.0 }, "period_end": "2020-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.4006809407144431, "roa_avg2y": -0.47275815042242125, "roa_period_end": -0.4505411073258352, "roe_avg2y": -0.6980839034908862, "roe_period_end": -0.6310643420396778 } }, { "accn": "0001564590-21-012501", "filed": "2022-03-17", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "cash": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 44425830.0, "net_income": -60826831.0, "operating_cash_flow": -44984226.0, "operating_income": -63074307.0, "stockholders_equity": 48082317.0, "total_assets": 75518281.0, "total_liabilities": 27435964.0 }, "period_end": "2019-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.5706040330793543, "roa_avg2y": -0.7130535382579894, "roa_period_end": -0.8054583631213745, "roe_avg2y": -0.9031432417936186, "roe_period_end": -1.265056153595926 } }, { "accn": "0001564590-21-012501", "filed": "2021-03-11", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "cash": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 47357472.0, "net_income": -38893245.0, "operating_cash_flow": -29857131.0, "operating_income": -39699151.0, "stockholders_equity": 86617979.0, "total_assets": 95091155.0, "total_liabilities": 8473176.0 }, "period_end": "2018-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.09782237011094429, "roa_avg2y": -0.5585457102547265, "roa_period_end": -0.4090101229709535, "roe_avg2y": -0.616281948300683, "roe_period_end": -0.449020462599341 } }, { "accn": "0001564590-20-010493", "filed": "2020-03-12", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "cash": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 20023337.0, "net_income": -22340589.0, "operating_cash_flow": -19222862.0, "operating_income": -22488388.0, "stockholders_equity": 39601019.0, "total_assets": 44174958.0, "total_liabilities": 4573939.0 }, "period_end": "2017-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.11550053800383268, "roa_avg2y": -0.644167810402018, "roa_period_end": -0.5057297168228208, "roe_avg2y": -0.7294786637687688, "roe_period_end": -0.5641417712003824 } }, { "accn": "0001564590-19-006997", "filed": "2019-03-08", "fiscal_year": 2016, "form": "10-K", "fundamental_units": { "cash": "USD", "net_income": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 12015061.0, "net_income": -18699450.0, "operating_income": -18695978.0, "stockholders_equity": 21649817.0, "total_assets": 25187679.0, "total_liabilities": 3537862.0 }, "period_end": "2016-12-31", "ratio_units": { "leverage": "ratio", "roa_period_end": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.16341302099689803, "roa_period_end": -0.7424046495113743, "roe_period_end": -0.8637232360901712 } }, { "accn": "0001193125-17-104228", "filed": "2017-03-30", "fiscal_year": 2015, "form": "10-K", "fundamental_units": { "cash": "USD", "eps_diluted": "USD/shares" }, "fundamentals": { "cash": 14648866.0, "eps_diluted": -1.4 }, "period_end": "2015-12-31", "ratios": {} }, { "accn": "0001193125-16-523952", "filed": "2016-03-30", "fiscal_year": 2014, "form": "10-K", "fundamental_units": { "eps_diluted": "USD/shares" }, "fundamentals": { "eps_diluted": -3.09 }, "period_end": "2014-12-31", "ratios": {} }, { "accn": "0001193125-15-101703", "filed": "2015-03-23", "fiscal_year": 2013, "form": "10-K", "fundamental_units": { "eps_diluted": "USD/shares" }, "fundamentals": { "eps_diluted": -17.61 }, "period_end": "2013-12-31", "ratios": {} } ], "latest_filing": { "accn": "0001193125-26-083012", "filed": "2026-02-27", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2834", "sic_description": "Pharmaceutical Preparations", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001341235.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001341235.json" }, "ticker": "ALDX" }